Abcam, ab318957, Anti-E2F2 antibody [EPR27391-170] - BSA and Azide free

Size: 100µg / 1mg
Rabbit Recombinant Monoclonal E2F2 antibody. Carrier free. Suitable for WB, IP, ChIP-seq and reacts with Recombinant full length protein - Human, Human samples.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR27391-170,
Isotype:IgG,
Carrier free:Yes,
Reacts with:Human,
Applications:IP, WB, ChIP-seqSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.

Product details:
ab318957 is the carrier-free version of
ab318956
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our
conjugation kits
for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar
Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar
is a trademark of Fluidigm Canada Inc.

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Constituents: PBS, Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
E2F2 also known as E2F transcription factor 2 is a member of the E2F family of transcription factors. It is a protein with a mass of approximately 46 kDa. It plays an important role by regulating the expression of genes involved in cell cycle progression particularly the transition from G1 to S phase. Researchers have identified that E2F2 is expressed in various tissues with high expression noted in actively dividing cells such as those in fetal tissues adult testis and tumor cells.
Biological function summary
E2F2 functions as a transcriptional activator and repressor controlling genes necessary for DNA synthesis and cell cycle progression. It often associates with retinoblastoma protein (RB1) to form complexes that finely regulate gene transcription. E2F2 not only controls cell proliferation but also influences cell differentiation processes by coordinating the balance between distinct cellular states.
Pathways
E2F2 interacts with key players in the cell cycle such as cyclins and cyclin-dependent kinases (CDKs). It is an integral part of the Rb-E2F signaling pathway which governs cell cycle checkpoints and progression. This pathway's regulation heavily influences the activities of other E2F family members such as E2F1 and E2F3 which can either promote or inhibit cell cycle transitions in response to various signals.
E2F2's dysregulation associates with cancer and retinoblastoma. Uncontrolled E2F2 activity often contributes to tumorigenesis by bypassing cell cycle controls resulting in unchecked cell division. In cancer altered interactions between E2F2 and proteins like RB1 can lead to the loss of tumor suppressor functions such as those observed in certain aggressive tumors. Understanding these interactions can provide insights into therapeutic targets for cancer treatment.